+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Discovery Market - Global Forecast 2026-2032- Product Image
Drug Discovery Market - Global Forecast 2026-2032- Product Image
Sale

Drug Discovery Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083874
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Discovery Market is projected to reach USD 93.63 Billion in 2026. It is expected to continue growing at a CAGR of 13.52%, reaching USD 200.84 Billion by 2032.

Drug discovery is moving from a sequential, chemistry-led process toward an integrated, data-rich operating model that connects target biology, translational medicine, clinical evidence, and manufacturing readiness earlier in development. The sector remains defined by high scientific risk: only a minority of drug candidates entering human testing ultimately reach approval, and end-to-end development timelines commonly extend across a decade when discovery, preclinical, clinical, and regulatory activities are considered.

Recent approval activity underscores both resilience and selectivity in the innovation system. The U.S. FDA Center for Drug Evaluation and Research approved 55 novel drugs in 2023 and 50 in 2024, demonstrating sustained regulatory throughput after the 2022 slowdown. For executives, the priority is no longer simply generating more molecules; it is improving the probability that the right molecule, therapeutic modality, biomarker strategy, and patient population converge before expensive late-stage trials begin.

Transformative Shifts in the Drug Discovery Landscape

The drug discovery landscape is being reshaped by precision biology, multi-omics, high-throughput screening, phenotypic assays, structure-based drug design, and increasingly diverse therapeutic modalities including biologics, cell and gene therapies, RNA-based medicines, antibody-drug conjugates, and targeted protein degraders. These shifts are expanding the addressable disease space while increasing the need for specialized platforms, validated datasets, and cross-functional expertise.

Capital allocation is also becoming more disciplined. Following tighter financing conditions for biotechnology companies, pipelines are being prioritized around differentiated mechanisms, human genetic validation, biomarker-enriched indications, and assets with clearer clinical and commercial positioning. Strategic partnerships between pharmaceutical companies, biotechnology innovators, contract research organizations, academic centers, and technology providers are therefore becoming central to risk-sharing, translational validation, and speed-to-decision.

Cumulative Impact of Artificial Intelligence on Drug Discovery

Artificial intelligence is now a cumulative force across target identification, protein structure prediction, molecular generation, ADMET modeling, literature mining, patient stratification, and clinical trial design. The impact is strongest when AI is paired with high-quality experimental data, reproducible assay systems, domain expertise, and prospective validation. The public protein-structure database associated with AlphaFold, which expanded to more than 200 million predicted structures, illustrates how computational biology can compress early hypothesis generation and broaden access to structural insight.

However, AI does not remove the biological uncertainty that drives attrition in drug discovery. Model performance depends on data provenance, assay relevance, chemical diversity, bias control, and explainability. The most successful organizations are treating AI as an evidence accelerator rather than a replacement for wet-lab validation, using closed-loop workflows that connect in silico predictions with automated synthesis, biological screening, and iterative experimental learning.

Key Regional Insights Across Global Drug Discovery

Asia-Pacific is becoming a major center for drug discovery scale, supported by China’s expanding biotechnology ecosystem, Japan’s established pharmaceutical base, South Korea’s biologics and translational research strengths, India’s chemistry and clinical development capabilities, and Australia’s academic-to-clinical innovation networks. The region benefits from large patient populations, growing clinical trial capacity, strong contract research and manufacturing expertise, and policy efforts that encourage domestic life sciences innovation, particularly in oncology, immunology, infectious diseases, and advanced biologics.

North America remains the leading hub for venture-backed biotechnology, academic research commercialization, regulatory precedent, and specialized service providers, with the United States anchoring global innovation density and Canada adding recognized strengths in artificial intelligence, structural biology, and translational research. Europe continues to contribute through strong public research systems, the European Medicines Agency framework, multinational clinical networks, and deep capabilities in biologics, rare diseases, oncology, vaccines, and advanced therapies. Latin America is gaining relevance for clinical trial participation, epidemiological diversity, and regional market access, with Brazil and Mexico playing important roles in patient recruitment and medical research capacity. The Middle East is strengthening precision medicine, genomics, and health innovation strategies through national healthcare transformation programs, while Africa is advancing genomics, infectious disease research, and public health-linked discovery capabilities, although research infrastructure and regulatory capacity remain uneven across countries.

Key Group Insights for Drug Discovery Strategy

ASEAN is emerging as a pragmatic clinical research and manufacturing-adjacent region, supported by Singapore’s biomedical R&D base, Malaysia’s and Thailand’s clinical infrastructure, and broader regional demand for affordable therapeutics. The GCC is investing in genomics, precision medicine, biobanking, and health system modernization, creating opportunities for research partnerships aligned with population health priorities, inherited disease programs, oncology, metabolic disorders, and digital health-enabled clinical evidence generation.

The European Union provides one of the world’s most structured regulatory and research environments, strengthened by Horizon Europe funding, cross-border clinical networks, health data initiatives, and harmonized medicines evaluation. BRICS countries offer large patient populations, growing scientific talent, expanding clinical development capacity, and cost-competitive research infrastructure, although regulatory consistency, intellectual property enforcement, and data standards vary by country. The G7 continues to dominate high-value drug discovery, intellectual property generation, advanced therapeutic development, and regulatory science, while NATO-aligned countries contribute substantially to biosecurity, resilient pharmaceutical supply chains, pandemic preparedness, and dual-use biotechnology governance.

Key Country Insights in Drug Discovery Innovation

The United States leads global drug discovery through the concentration of NIH-funded research, venture capital, FDA regulatory experience, biotechnology clusters, specialized service providers, and large pharmaceutical research operations. Canada contributes strengths in AI-enabled drug discovery, structural biology, oncology, immunology, and academic spinouts, while Mexico and Brazil provide important clinical research capacity, epidemiological diversity, and growing life sciences capabilities in Latin America, particularly for trials that require broad patient access and regional healthcare system engagement.

In Europe, the United Kingdom remains a leading center for genomics, clinical research, translational medicine, and biotechnology financing; Germany is strong in medicinal chemistry, biopharma manufacturing, vaccines, and translational medicine; France, Italy, and Spain add major academic hospitals, oncology research, rare disease expertise, and clinical trial networks; and Russia retains scientific depth in chemistry, biology, and infectious disease research but faces constraints from geopolitical and market-access factors. In Asia-Pacific, China has rapidly expanded discovery pipelines and regulatory modernization, India remains a major chemistry, generics, vaccine, and services hub, Japan provides mature pharmaceutical innovation and strong regulatory science, South Korea is recognized for biologics, cell therapy, and digital health integration, and Australia offers efficient early-phase clinical development, strong biomedical research institutions, and globally connected translational research networks.

Actionable Recommendations for Drug Discovery Leaders

Industry leaders should prioritize portfolio decisions around human biology, biomarker feasibility, competitive differentiation, and clinical translatability rather than discovery volume alone. Investments in data governance, interoperable laboratory systems, assay quality, reproducible experimental design, and FAIR data principles are essential for extracting value from AI, automation, and multi-omics platforms.

Vendors should also build partnership models that combine internal scientific judgment with external platform access, including academic collaborations, contract research capabilities, real-world data networks, and computational biology providers. To reduce late-stage failure, teams should integrate CMC, toxicology, regulatory strategy, clinical operations, and payer evidence requirements earlier in discovery and lead optimization, while maintaining clear go/no-go criteria tied to translational evidence.

Research Methodology for Drug Discovery Analysis

This executive summary is developed using a secondary research methodology grounded in publicly available and verifiable sources, including regulatory approval data, peer-reviewed scientific literature, government research agencies, clinical trial registries, public policy documents, and recognized life sciences industry evidence. Emphasis is placed on information traceable to authoritative institutions such as FDA, EMA, NIH, WHO, OECD, national health agencies, and leading scientific publications.

Insights are synthesized through triangulation across regulatory trends, scientific developments, technology adoption, regional policy signals, clinical trial activity, and commercial pipeline behavior. Market interpretation avoids unsupported projections and focuses on observable indicators such as approval counts, R&D activity, clinical infrastructure, therapeutic modality expansion, regulatory modernization, and validated technology adoption patterns.

Conclusion: Drug Discovery Advantage Through Evidence-Led Innovation

Drug discovery is entering a more integrated era in which biology, computation, automation, clinical insight, and regulatory planning must operate as a single evidence system. AI, multi-omics, and advanced therapeutic modalities are improving the speed and precision of early research, but durable value will depend on validation quality, translational relevance, clinical feasibility, and disciplined portfolio governance.

Organizations that combine data integrity, scientific rigor, global partnership networks, and patient-centered development strategies will be best positioned to convert discovery potential into approved therapies. The competitive advantage will belong to teams that can reduce uncertainty earlier, allocate capital more intelligently, and deliver medicines with clearer clinical and therapeutic impact.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Scale AI-Enabled Discovery Only Where It Shortens Validated Decision Cycles
4.3.1.2. Capture Modality-Specific Demand From Biologics and Next-Generation Therapeutics
4.3.1.3. Convert Outsourced R&D Demand Into Strategic Discovery Partnerships
4.3.1.4. Prioritize Human-Relevant Models to Reduce Downstream Attrition
4.3.2. Key Restraints
4.3.2.1. Reduce Adoption Friction From High Upfront Cost and ROI Uncertainty
4.3.2.2. Overcome Fragmented Data Infrastructure Before Scaling AI and Automation
4.3.3. Key Opportunities
4.3.3.1. Monetize Integrated Design-Make-Test-Learn Platforms
4.3.3.2. Build Multiomics-to-Insight Offerings for Translational Decision-Making
4.3.3.3. Capture Supplier Diversification Demand With Trusted Regional Capacity
4.3.4. Key Challenges
4.3.4.1. Build Geopolitical Resilience Into Supplier and Data Strategies
4.3.4.2. Prove That Faster Discovery Workflows Improve Translational Success
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Drug Discovery Market, by Offering
7.1. Introduction
7.2. Instruments & Automation
7.2.1. High-Throughput Screening Systems
7.2.1.1. Microplate Readers
7.2.1.2. Time-Resolved Fluorescence Readers
7.2.1.3. Fluorescence Polarization Readers
7.2.1.4. AlphaScreen & AlphaLISA Detection Systems
7.2.1.5. Automated Plate Washers
7.2.1.6. Automated Plate Dispensers
7.2.1.7. Automated Incubation Systems
7.2.1.8. Automated Plate Handling Systems
7.2.1.9. Colony Pickers
7.2.1.10. Microplate Sealing & De-Sealing Systems
7.2.2. Liquid Handling & Sample Preparation Automation Systems
7.2.2.1. Automated Liquid Handling Systems
7.2.2.2. Automated Pipetting Systems
7.2.2.3. Automated Sample Preparation Systems
7.2.2.4. Laboratory Scheduling & Workflow Systems
7.2.2.5. Microplate Replicators
7.2.2.6. Automated Compound Reformatting Systems
7.2.2.7. Dispensing Systems
7.2.2.8. Automated Dilution Systems
7.2.3. High-Content Imaging & Phenotypic Screening Systems
7.2.3.1. Confocal Imaging Systems
7.2.3.2. Widefield Fluorescence Imaging Systems
7.2.3.3. Live-Cell Imaging Systems & Label-Free Imaging Systems
7.2.3.4. Automated Microscopy Platforms
7.2.3.5. Image-Based Cytometry Systems
7.2.3.6. Organoid & Three-Dimensional Culture Imaging Systems
7.2.3.7. Phenotypic Profiling Systems
7.2.4. Laboratory Robotics & Integrated Automation Systems
7.2.4.1. Robotic Laboratory Arms
7.2.4.2. Automated Workcells
7.2.5. Analytical Chemistry Instruments
7.2.5.1. Liquid Chromatography Systems
7.2.5.2. Gas Chromatography Systems
7.2.5.3. Liquid Chromatography-Mass Spectrometry Systems
7.2.5.4. Tandem Mass Spectrometry Systems
7.2.5.5. Capillary Electrophoresis Systems
7.2.5.6. Preparative Chromatography Systems
7.2.5.7. Elemental Analysis Systems
7.2.6. Biophysical Characterization & Binding Analysis Instruments
7.2.6.1. Surface Plasmon Resonance Systems
7.2.6.2. Bio-Layer Interferometry Systems
7.2.6.3. Isothermal Titration Calorimetry Systems
7.2.6.4. Microscale Thermophoresis Systems
7.2.6.5. Differential Scanning Fluorimetry Systems
7.2.6.6. Quartz Crystal Microbalance Systems
7.2.6.7. Label-Free Binding Analysis Systems
7.2.7. Structural Biology Instruments
7.2.7.1. X-Ray Crystallography Systems
7.2.7.2. Protein Crystallization Screening Systems
7.2.7.3. Cryo-Electron Microscopy Systems
7.2.7.4. Cryo-EM Sample Preparation Systems
7.2.7.5. Nuclear Magnetic Resonance Spectroscopy Systems
7.2.7.6. Small-Angle X-Ray Scattering Systems
7.2.7.7. Protein Crystallization Imaging Systems
7.2.7.8. Hydrogen-Deuterium Exchange Mass Spectrometry Systems
7.2.8. Cell Analysis And Single-Cell Analysis Instruments
7.2.8.1. Flow Cytometers
7.2.8.2. Cell Sorting Systems
7.2.8.3. Single-Cell Analysis Platforms
7.2.8.4. Automated Cell Counters
7.2.8.5. Cell Viability Analyzers
7.2.8.6. Cell Migration & Invasion Analysis Systems
7.2.8.7. Cell Metabolism Analyzers
7.2.8.8. Electrophysiology Screening Systems
7.2.9. Genomics, Transcriptomics, Proteomics, & Multiomics Instruments
7.2.9.1. Next-Generation Sequencing Systems
7.2.9.2. Single-Cell Sequencing Platforms
7.2.9.3. Spatial Biology Platforms
7.2.9.4. PCR Systems
7.2.9.5. Microarray Platforms
7.2.9.6. Metabolomics Platforms
7.2.10. In Vivo Pharmacology & Preclinical Research Instruments
7.2.10.1. Micro-Computed Tomography Systems
7.2.10.2. In Vivo Optical Imaging Systems
7.2.10.3. Micro-Magnetic Resonance Imaging Systems
7.2.10.4. Micro-Positron Emission Tomography Systems
7.2.10.5. Telemetry Systems
7.2.10.6. Metabolic Cage Systems
7.2.10.7. Disease Monitoring Systems
7.2.10.8. Small Animal Dosing & Sampling Systems
7.3. Reagents, Consumables, & Libraries
7.3.1. Biochemical Reagents
7.3.2. Chromatography Consumables
7.3.3. Cell Lines & Disease Models;
7.3.4. Antibody & Protein Reagents
7.3.5. Microplates, Tips, & Lab Plastics
7.3.6. Assay Kits
7.3.7. Compound Libraries
7.4. Software
7.4.1. Molecular Modeling & Simulation Software
7.4.2. Lab Informatics & Workflow Orchestration
7.4.3. AI & Machine Learning Platforms
7.4.4. Bioinformatics & Multiomics Analytics
7.4.5. Data Integration & Knowledge Graph Platforms
7.5. Services
7.5.1. Target Identification & Validation Services
7.5.2. Assay Development Services
7.5.3. Screening Services
7.5.4. Hit-To-Lead Services
7.5.5. Lead Optimization Services
7.5.6. Medicinal Chemistry Services
7.5.7. DMPK Services
7.5.8. Toxicology Services
7.5.9. Structural Biology Services
8. Drug Discovery Market, by Drug Modality
8.1. Introduction
8.2. Small Molecules
8.2.1. Conventional Small Molecules
8.2.2. Targeted Protein Degraders
8.2.3. Complex Small Molecules
8.3. Biologics
8.3.1. Antibody-Based
8.3.2. Protein-Based
8.3.3. Peptide-Based
8.4. Nucleic Acid Therapies
8.4.1. RNA-Based
8.4.2. DNA-Based
8.4.3. Gene Therapy Vectors
8.5. Cell Therapies
8.5.1. Immune Cell Therapies
8.5.2. Regenerative Cell Therapies
8.5.3. Engineered Cell Therapies
9. Drug Discovery Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular
9.3. Metabolic
9.4. Immunology
9.5. Central Nervous System
9.6. Oncology
9.7. Infectious Diseases
9.8. Respiratory
9.9. Rare Diseases
10. Drug Discovery Market, by End User
10.1. Introduction
10.2. Pharmaceutical Companies
10.3. Biotechnology Companies
10.4. Academic & Research Institutes
10.5. Contract Research Organizations
11. Drug Discovery Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Drug Discovery Market, by Group
12.1. NATO
12.2. G7
12.3. European Union
12.4. BRICS
12.5. ASEAN
12.6. GCC
13. Drug Discovery Market, by Country
13.1. United States
13.2. China
13.3. Germany
13.4. Japan
13.5. India
13.6. Canada
13.7. United Kingdom
13.8. France
13.9. Brazil
13.10. Mexico
13.11. Australia
13.12. Italy
13.13. South Korea
13.14. Russia
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Thermo Fisher Scientific Inc.
15.2. Charles River Laboratories International, Inc.
15.3. WuXi AppTec Co., Ltd.
15.4. Danaher Corporation
15.5. Eurofins Scientific SE
15.6. Agilent Technologies, Inc.
15.7. Merck KGaA
15.8. Pharmaron Beijing Co., Ltd.
15.9. Labcorp Holdings Inc.
15.10. Evotec SE
15.11. Avantor, Inc.
15.12. Waters Corporation
15.13. IQVIA Holdings Inc.
15.14. Revvity, Inc.
15.15. Bruker Corporation
15.16. Illumina, Inc.
15.17. Syngene International Limited
15.18. Sartorius AG
15.19. Bio-Rad Laboratories, Inc.
15.20. Aragen Life Sciences Limited
15.21. Corning Incorporated
15.22. Inotiv, Inc.
15.23. Curia Global, Inc.
15.24. Tecan Group Ltd.
15.25. Schrödinger, Inc.
15.26. 10x Genomics, Inc.
15.27. Benchling, Inc.
15.28. XtalPi Holdings Limited
15.29. Certara, Inc.
15.30. Recursion Pharmaceuticals, Inc.
15.31. AbCellera Biologics Inc.
15.32. Absci Corporation
15.33. Adimab, LLC
15.34. Atomwise Inc.
15.35. BenevolentAI S.A.
15.36. ChemPartner Pharmatech Co., Ltd.
15.37. Collaborative Drug Discovery, Inc.
15.38. Crown Bioscience International
15.39. Dassault Systèmes SE
15.40. Domainex Limited
15.41. Dotmatics Limited
15.42. Generate Biomedicines, Inc.
15.43. Ginkgo Bioworks Holdings, Inc.
15.44. Iktos SAS
15.45. Insilico Medicine Cayman TopCo
15.46. Isomorphic Labs Limited
15.47. Jubilant Biosys Limited
15.48. Lonza Group AG
15.49. OmniAb, Inc.
15.50. Owkin, Inc.
15.51. Relay Therapeutics, Inc.
15.52. Sai Life Sciences Limited
15.53. Selvita S.A.
15.54. Shanghai Medicilon Inc.
15.55. Sygnature Discovery Limited
15.56. Taconic Biosciences, Inc.
15.57. TCG Lifesciences Private Limited
15.58. The Jackson Laboratory
15.59. Twist Bioscience Corporation
15.60. Viva Biotech Holdings
List of Figures
FIGURE 1. GLOBAL DRUG DISCOVERY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DRUG DISCOVERY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DRUG DISCOVERY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DRUG DISCOVERY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DRUG DISCOVERY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG MODALITY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DRUG DISCOVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS & AUTOMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS & AUTOMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS & AUTOMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL HIGH-THROUGHPUT SCREENING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL HIGH-THROUGHPUT SCREENING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL HIGH-THROUGHPUT SCREENING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MICROPLATE READERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MICROPLATE READERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MICROPLATE READERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL TIME-RESOLVED FLUORESCENCE READERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL TIME-RESOLVED FLUORESCENCE READERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL TIME-RESOLVED FLUORESCENCE READERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL FLUORESCENCE POLARIZATION READERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FLUORESCENCE POLARIZATION READERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FLUORESCENCE POLARIZATION READERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ALPHASCREEN & ALPHALISA DETECTION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ALPHASCREEN & ALPHALISA DETECTION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ALPHASCREEN & ALPHALISA DETECTION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED PLATE WASHERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED PLATE WASHERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED PLATE WASHERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED PLATE DISPENSERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED PLATE DISPENSERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED PLATE DISPENSERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED INCUBATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED INCUBATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED INCUBATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED PLATE HANDLING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED PLATE HANDLING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED PLATE HANDLING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL COLONY PICKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL COLONY PICKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL COLONY PICKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MICROPLATE SEALING & DE-SEALING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MICROPLATE SEALING & DE-SEALING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MICROPLATE SEALING & DE-SEALING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL LIQUID HANDLING & SAMPLE PREPARATION AUTOMATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL LIQUID HANDLING & SAMPLE PREPARATION AUTOMATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL LIQUID HANDLING & SAMPLE PREPARATION AUTOMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED LIQUID HANDLING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED LIQUID HANDLING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED LIQUID HANDLING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED PIPETTING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED PIPETTING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED PIPETTING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED SAMPLE PREPARATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED SAMPLE PREPARATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED SAMPLE PREPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL LABORATORY SCHEDULING & WORKFLOW SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL LABORATORY SCHEDULING & WORKFLOW SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL LABORATORY SCHEDULING & WORKFLOW SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL MICROPLATE REPLICATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL MICROPLATE REPLICATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL MICROPLATE REPLICATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED COMPOUND REFORMATTING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED COMPOUND REFORMATTING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED COMPOUND REFORMATTING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DISPENSING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DISPENSING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL DISPENSING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED DILUTION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED DILUTION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED DILUTION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HIGH-CONTENT IMAGING & PHENOTYPIC SCREENING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HIGH-CONTENT IMAGING & PHENOTYPIC SCREENING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HIGH-CONTENT IMAGING & PHENOTYPIC SCREENING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CONFOCAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CONFOCAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CONFOCAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL WIDEFIELD FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL WIDEFIELD FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL WIDEFIELD FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL LIVE-CELL IMAGING SYSTEMS & LABEL-FREE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL LIVE-CELL IMAGING SYSTEMS & LABEL-FREE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL LIVE-CELL IMAGING SYSTEMS & LABEL-FREE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL AUTOMATED MICROSCOPY PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AUTOMATED MICROSCOPY PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AUTOMATED MICROSCOPY PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL IMAGE-BASED CYTOMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL IMAGE-BASED CYTOMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL IMAGE-BASED CYTOMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ORGANOID & THREE-DIMENSIONAL CULTURE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ORGANOID & THREE-DIMENSIONAL CULTURE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ORGANOID & THREE-DIMENSIONAL CULTURE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PHENOTYPIC PROFILING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PHENOTYPIC PROFILING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL PHENOTYPIC PROFILING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL LABORATORY ROBOTICS & INTEGRATED AUTOMATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL LABORATORY ROBOTICS & INTEGRATED AUTOMATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL LABORATORY ROBOTICS & INTEGRATED AUTOMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ROBOTIC LABORATORY ARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ROBOTIC LABORATORY ARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ROBOTIC LABORATORY ARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL AUTOMATED WORKCELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL AUTOMATED WORKCELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL AUTOMATED WORKCELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ANALYTICAL CHEMISTRY INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ANALYTICAL CHEMISTRY INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ANALYTICAL CHEMISTRY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL LIQUID CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL LIQUID CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL LIQUID CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL GAS CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL GAS CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL GAS CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL TANDEM MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL TANDEM MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL TANDEM MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL CAPILLARY ELECTROPHORESIS SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL CAPILLARY ELECTROPHORESIS SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL CAPILLARY ELECTROPHORESIS SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL PREPARATIVE CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL PREPARATIVE CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL PREPARATIVE CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ELEMENTAL ANALYSIS SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ELEMENTAL ANALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ELEMENTAL ANALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL BIOPHYSICAL CHARACTERIZATION & BINDING ANALYSIS INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL BIOPHYSICAL CHARACTERIZATION & BINDING ANALYSIS INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL BIOPHYSICAL CHARACTERIZATION & BINDING ANALYSIS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL SURFACE PLASMON RESONANCE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL SURFACE PLASMON RESONANCE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL SURFACE PLASMON RESONANCE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL BIO-LAYER INTERFEROMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL BIO-LAYER INTERFEROMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL BIO-LAYER INTERFEROMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ISOTHERMAL TITRATION CALORIMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL ISOTHERMAL TITRATION CALORIMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL ISOTHERMAL TITRATION CALORIMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL MICROSCALE THERMOPHORESIS SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL MICROSCALE THERMOPHORESIS SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL MICROSCALE THERMOPHORESIS SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL DIFFERENTIAL SCANNING FLUORIMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL DIFFERENTIAL SCANNING FLUORIMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL DIFFERENTIAL SCANNING FLUORIMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL QUARTZ CRYSTAL MICROBALANCE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL QUARTZ CRYSTAL MICROBALANCE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL QUARTZ CRYSTAL MICROBALANCE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL LABEL-FREE BINDING ANALYSIS SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL LABEL-FREE BINDING ANALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL LABEL-FREE BINDING ANALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL STRUCTURAL BIOLOGY INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL STRUCTURAL BIOLOGY INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL STRUCTURAL BIOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL X-RAY CRYSTALLOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL X-RAY CRYSTALLOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL X-RAY CRYSTALLOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL PROTEIN CRYSTALLIZATION SCREENING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL PROTEIN CRYSTALLIZATION SCREENING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PROTEIN CRYSTALLIZATION SCREENING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL CRYO-ELECTRON MICROSCOPY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL CRYO-ELECTRON MICROSCOPY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL CRYO-ELECTRON MICROSCOPY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL CRYO-EM SAMPLE PREPARATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL CRYO-EM SAMPLE PREPARATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL CRYO-EM SAMPLE PREPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL SMALL-ANGLE X-RAY SCATTERING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL SMALL-ANGLE X-RAY SCATTERING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL SMALL-ANGLE X-RAY SCATTERING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL PROTEIN CRYSTALLIZATION IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL PROTEIN CRYSTALLIZATION IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL PROTEIN CRYSTALLIZATION IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL HYDROGEN-DEUTERIUM EXCHANGE MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL HYDROGEN-DEUTERIUM EXCHANGE MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL HYDROGEN-DEUTERIUM EXCHANGE MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL CELL ANALYSIS AND SINGLE-CELL ANALYSIS INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL CELL ANALYSIS AND SINGLE-CELL ANALYSIS INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL CELL ANALYSIS AND SINGLE-CELL ANALYSIS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL CELL SORTING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL CELL SORTING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL CELL SORTING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL SINGLE-CELL ANALYSIS PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL SINGLE-CELL ANALYSIS PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL SINGLE-CELL ANALYSIS PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 190. GLOBAL CELL VIABILITY ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL CELL VIABILITY ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL CELL VIABILITY ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 193. GLOBAL CELL MIGRATION & INVASION ANALYSIS SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 194. GLOBAL CELL MIGRATION & INVASION ANALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 195. GLOBAL CELL MIGRATION & INVASION ANALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL CELL METABOLISM ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 197. GLOBAL CELL METABOLISM ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL CELL METABOLISM ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 199. GLOBAL ELECTROPHYSIOLOGY SCREENING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL ELECTROPHYSIOLOGY SCREENING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 201. GLOBAL ELECTROPHYSIOLOGY SCREENING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 202. GLOBAL GENOMICS, TRANSCRIPTOMICS, PROTEOMICS, & MULTIOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 203. GLOBAL GENOMICS, TRANSCRIPTOMICS, PROTEOMICS, & MULTIOMICS INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. GLOBAL GENOMICS, TRANSCRIPTOMICS, PROTEOMICS, & MULTIOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL NEXT-GENERATION SEQUENCING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL NEXT-GENERATION SEQUENCING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. GLOBAL NEXT-GENERATION SEQUENCING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL SINGLE-CELL SEQUENCING PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 209. GLOBAL SINGLE-CELL SEQUENCING PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 210. GLOBAL SINGLE-CELL SEQUENCING PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL SPATIAL BIOLOGY PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 212. GLOBAL SPATIAL BIOLOGY PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL SPATIAL BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 214. GLOBAL PCR SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 215. GLOBAL PCR SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 216. GLOBAL PCR SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 217. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 218. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 219. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 220. GLOBAL METABOLOMICS PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 221. GLOBAL METABOLOMICS PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. GLOBAL METABOLOMICS PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 223. GLOBAL IN VIVO PHARMACOLOGY & PRECLINICAL RESEARCH INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 224. GLOBAL IN VIVO PHARMACOLOGY & PRECLINICAL RESEARCH INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 225. GLOBAL IN VIVO PHARMACOLOGY & PRECLINICAL RESEARCH INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 226. GLOBAL MICRO-COMPUTED TOMOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 227. GLOBAL MICRO-COMPUTED TOMOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. GLOBAL MICRO-COMPUTED TOMOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 229. GLOBAL IN VIVO OPTICAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 230. GLOBAL IN VIVO OPTICAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 231. GLOBAL IN VIVO OPTICAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 232. GLOBAL MICRO-MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 233. GLOBAL MICRO-MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. GLOBAL MICRO-MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 235. GLOBAL MICRO-POSITRON EMISSION TOMOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 236. GLOBAL MICRO-POSITRON EMISSION TOMOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. GLOBAL MICRO-POSITRON EMISSION TOMOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 238. GLOBAL TELEMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 239. GLOBAL TELEMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 240. GLOBAL TELEMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 241. GLOBAL METABOLIC CAGE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 242. GLOBAL METABOLIC CAGE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 243. GLOBAL METABOLIC CAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 244. GLOBAL DISEASE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 245. GLOBAL DISEASE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. GLOBAL DISEASE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 247. GLOBAL SMALL ANIMAL DOSING & SAMPLING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 248. GLOBAL SMALL ANIMAL DOSING & SAMPLING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 249. GLOBAL SMALL ANIMAL DOSING & SAMPLING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 250. GLOBAL REAGENTS, CONSUMABLES, & LIBRARIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 251. GLOBAL REAGENTS, CONSUMABLES, & LIBRARIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 252. GLOBAL REAGENTS, CONSUMABLES, & LIBRARIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 253. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 254. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 255. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 256. GLOBAL CHROMATOGRAPHY CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 257. GLOBAL CHROMATOGRAPHY CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 258. GLOBAL CHROMATOGRAPHY CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 259. GLOBAL CELL LINES & DISEASE MODELS; MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 260. GLOBAL CELL LINES & DISEASE MODELS; MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 261. GLOBAL CELL LINES & DISEASE MODELS; MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 262. GLOBAL ANTIBODY & PROTEIN REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 263. GLOBAL ANTIBODY & PROTEIN REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 264. GLOBAL ANTIBODY & PROTEIN REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 265. GLOBAL MICROPLATES, TIPS, & LAB PLASTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 266. GLOBAL MICROPLATES, TIPS, & LAB PLASTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 267. GLOBAL MICROPLATES, TIPS, & LAB PLASTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 268. GLOBAL ASSAY KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 269. GLOBAL ASSAY KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. GLOBAL ASSAY KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 271. GLOBAL COMPOUND LIBRARIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 272. GLOBAL COMPOUND LIBRARIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 273. GLOBAL COMPOUND LIBRARIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 274. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 275. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 276. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 277. GLOBAL MOLECULAR MODELING & SIMULATION SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 278. GLOBAL MOLECULAR MODELING & SIMULATION SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 279. GLOBAL MOLECULAR MODELING & SIMULATION SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 280. GLOBAL LAB INFORMATICS & WORKFLOW ORCHESTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 281. GLOBAL LAB INFORMATICS & WORKFLOW ORCHESTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 282. GLOBAL LAB INFORMATICS & WORKFLOW ORCHESTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 283. GLOBAL AI & MACHINE LEARNING PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 284. GLOBAL AI & MACHINE LEARNING PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 285. GLOBAL AI & MACHINE LEARNING PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 286. GLOBAL BIOINFORMATICS & MULTIOMICS ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 287. GLOBAL BIOINFORMATICS & MULTIOMICS ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 288. GLOBAL BIOINFORMATICS & MULTIOMICS ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 289. GLOBAL DATA INTEGRATION & KNOWLEDGE GRAPH PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 290. GLOBAL DATA INTEGRATION & KNOWLEDGE GRAPH PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 291. GLOBAL DATA INTEGRATION & KNOWLEDGE GRAPH PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 292. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 293. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 294. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 295. GLOBAL TARGET IDENTIFICATION & VALIDATION SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 296. GLOBAL TARGET IDENTIFICATION & VALIDATION SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 297. GLOBAL TARGET IDENTIFICATION & VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 298. GLOBAL ASSAY DEVELOPMENT SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 299. GLOBAL ASSAY DEVELOPMENT SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 300. GLOBAL ASSAY DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 301. GLOBAL SCREENING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 302. GLOBAL SCREENING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 303. GLOBAL SCREENING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 304. GLOBAL HIT-TO-LEAD SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 305. GLOBAL HIT-TO-LEAD SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 306. GLOBAL HIT-TO-LEAD SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 307. GLOBAL LEAD OPTIMIZATION SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 308. GLOBAL LEAD OPTIMIZATION SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 309. GLOBAL LEAD OPTIMIZATION SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 310. GLOBAL MEDICINAL CHEMISTRY SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 311. GLOBAL MEDICINAL CHEMISTRY SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 312. GLOBAL MEDICINAL CHEMISTRY SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 313. GLOBAL DMPK SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 314. GLOBAL DMPK SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 315. GLOBAL DMPK SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 316. GLOBAL TOXICOLOGY SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 317. GLOBAL TOXICOLOGY SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 318. GLOBAL TOXICOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 319. GLOBAL STRUCTURAL BIOLOGY SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 320. GLOBAL STRUCTURAL BIOLOGY SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 321. GLOBAL STRUCTURAL BIOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 322. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG MODALITY, 2017-2032 (USD MILLION)
TABLE 323. GLOBAL SMALL MOLECULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 324. GLOBAL SMALL MOLECULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 325. GLOBAL SMALL MOLECULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 326. GLOBAL CONVENTIONAL SMALL MOLECULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 327. GLOBAL CONVENTIONAL SMALL MOLECULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 328. GLOBAL CONVENTIONAL SMALL MOLECULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 329. GLOBAL TARGETED PROTEIN DEGRADERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 330. GLOBAL TARGETED PROTEIN DEGRADERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 331. GLOBAL TARGETED PROTEIN DEGRADERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 332. GLOBAL COMPLEX SMALL MOLECULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 333. GLOBAL COMPLEX SMALL MOLECULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 334. GLOBAL COMPLEX SMALL MOLECULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 335. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 336. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Charles River Laboratories International, Inc.
  • WuXi AppTec Co., Ltd.
  • Danaher Corporation
  • Eurofins Scientific SE
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Pharmaron Beijing Co., Ltd.
  • Labcorp Holdings Inc.
  • Evotec SE
  • Avantor, Inc.
  • Waters Corporation
  • IQVIA Holdings Inc.
  • Revvity, Inc.
  • Bruker Corporation
  • Illumina, Inc.
  • Syngene International Limited
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Aragen Life Sciences Limited
  • Corning Incorporated
  • Inotiv, Inc.
  • Curia Global, Inc.
  • Tecan Group Ltd.
  • Schrödinger, Inc.
  • 10x Genomics, Inc.
  • Benchling, Inc.
  • XtalPi Holdings Limited
  • Certara, Inc.
  • Recursion Pharmaceuticals, Inc.
  • AbCellera Biologics Inc.
  • Absci Corporation
  • Adimab, LLC
  • Atomwise Inc.
  • BenevolentAI S.A.
  • ChemPartner Pharmatech Co., Ltd.
  • Collaborative Drug Discovery, Inc.
  • Crown Bioscience International
  • Dassault Systèmes SE
  • Domainex Limited
  • Dotmatics Limited
  • Generate Biomedicines, Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Iktos SAS
  • Insilico Medicine Cayman TopCo
  • Isomorphic Labs Limited
  • Jubilant Biosys Limited
  • Lonza Group AG
  • OmniAb, Inc.
  • Owkin, Inc.
  • Relay Therapeutics, Inc.
  • Sai Life Sciences Limited
  • Selvita S.A.
  • Shanghai Medicilon Inc.
  • Sygnature Discovery Limited
  • Taconic Biosciences, Inc.
  • TCG Lifesciences Private Limited
  • The Jackson Laboratory
  • Twist Bioscience Corporation
  • Viva Biotech Holdings

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 93.63 Billion
Forecasted Market Value ( USD ) by 2032 $ 200.84 Billion
Compound Annual Growth Rate13.5%
Regions CoveredGlobal
No. of Companies Mentioned60

Related Topics

Related Reports

mRNA Drug Discovery and Manufacturing Platforms Market - Strategic Insights and Forecasts (2026-2031) - Product Image

mRNA Drug Discovery and Manufacturing Platforms Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • 156 Pages
  • Global
From
High Content Screening Market - Global Forecast 2026-2032 - Product Image

High Content Screening Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Label-free Array System Market - Global Forecast 2026-2032 - Product Image

Label-free Array System Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing - Global Strategic Business Report - Product Image

Cancer Immunotherapy Drug Discovery Outsourcing - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
Compound Management - Global Strategic Business Report - Product Image

Compound Management - Global Strategic Business Report

  • Report
  • 234 Pages
  • Global
From

About the Drug Discovery Market

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs. The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.